InnovAge Holding Corp.
InnovAge Holding Corp. operates a PACE-based healthcare delivery platform for frail seniors, with care centered on all-inclusive, capitated services for participants who are often dually eligible for Medicare and Medicaid. The company is headquartered in Denver and runs one reportable segment, PACE, across centers in six U.S. states.
Fiscal year 2026 · change from previous year
Development 2021–2026
Business
Share of revenueIntegrated medical, social, and supportive care delivered through PACE centers and home/community services.
Monthly per-participant payments from Medicare and Medicaid under state PACE contracts.
Ancillary revenue mainly from state food grants and rent-related income.
Acquired pharmacy assets and related management services supporting participant medication needs.
Products
Reported · share of revenue- Capitation Revenue99.9 %
- Other Service Revenue0.1 %
Source: 10-K FY2026, revenue the company reports per product line (SEC XBRL). Shares are of the lines shown and add up to 100 %.
Customers
InnovAge serves older adults who are medically complex, often dual-eligible for Medicare and Medicaid, and eligible for nursing-home-level care but able to remain in the community with support. Its economic buyers are primarily government payors through capitated state PACE contracts, while participants and their families are the end users of the care model. The company also works with hospitals, health systems, and other care providers in joint ventures and referral relationships to expand access in target markets.
Older adults covered by both Medicare and Medicaid who need coordinated, all-inclusive care.
Participants meeting nursing-home-level-of-care criteria who use PACE to stay in the community.
State Medicaid agencies and Medicare arrangements that fund the capitated model.
Hospitals and local providers that support market entry, referrals, and joint ventures.
Strategy
InnovAge is focused on filling existing center capacity, opening de novo centers, and using tuck-in acquisitions and partnerships to expand its PACE platform. Management also emphasizes tighter regulatory compliance and stronger relationships with Medicare and Medicaid payors, since the model depends on stable capitated reimbursement and successful state contracting.
Higher participant density improves operating leverage in a capitated care model.
New centers expand the platform into attractive markets and support long-term unit economics.
Tuck-ins and joint ventures accelerate market entry and participant growth.
PACE operations depend on state and federal compliance to preserve contracts and avoid remediation costs.
Geography
InnovAge is a U.S.-only operator with centers in California, Colorado, Florida, New Mexico, Pennsylvania, and Virginia. Its footprint is concentrated in state-by-state PACE markets, where local contracting, regulatory compliance, and provider relationships determine growth. The company is also expanding through de novo centers and partnerships in selected target markets, including Florida.
Risks
InnovAge’s results depend on participant growth, state payor relationships, and strict compliance with PACE regulations, so execution failures can quickly affect revenue and margins. The company also faces healthcare-industry competition, cybersecurity and PHI/PII exposure, and added operational complexity from its new pharmacy business and debt maturities.
- Growth strategy may not prove viableImpact: HighLikelihood: High
Expansion depends on new geographies, participant recruitment, and successful center execution.
Exposure - Regulatory and contractual compliance failuresImpact: HighLikelihood: High
PACE is heavily regulated and state contracts must be maintained in good standing.
Exposure - Dependence on government payorsImpact: HighLikelihood: High
The model relies on Medicare and Medicaid capitation rates and state contracting.
Exposure: Revenue concentration in public payors
- Cybersecurity and privacy breachesImpact: MediumLikelihood: Medium
The company and vendors handle sensitive PHI/PII and face HIPAA-related obligations.
Exposure: Third-party service providers and internal systems
- Pharmacy business execution riskImpact: MediumLikelihood: Medium
InnovAge has limited prior experience operating pharmacy services and may not realize expected synergies.
Exposure: Acquired pharmacy assets and management services agreement
- Refinancing and liquidity riskImpact: MediumLikelihood: Medium
Debt maturities can pressure cash flow and require refinancing on acceptable terms.
Exposure: Term loan maturity and revolving facility usage
Accounting
Judgemental itemsRevenue is based on PMPM payments under Medicare and Medicaid PACE contracts.
Impact: Affects timing and stability of reported revenue
Medical, housing, outpatient, and pharmacy costs are major expense drivers.
Impact: Affects margins and quarterly earnings volatility
The company recently acquired pharmacy assets and must value related assets and liabilities.
Impact: Can affect amortization, goodwill, and future impairment risk
PACE centers require facility build-outs and lease commitments.
Impact: Affects right-of-use assets, depreciation, and occupancy costs
Similar listed companies
Publicly listed companies with a comparable business focus.
Pennant Group, Inc.
PNTG · Services-Health Services
Inuvo, Inc.
INUV · Services-Advertising
INNOVATE Corp.
VATE · Fabricated Structural Metal Products
PACS Group, Inc.
PACS · Services-Skilled Nursing Care Facilities
Enhabit, Inc.
Services-Home Health Care Services
BioAge Labs, Inc.
BIOA · Pharmaceutical Preparations
Last updated: 24/09/2026